Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVMI
2476
Nova
NVMI
$13B
| $680K | ﹤0.01% |
5,795
+5,001
| +630% | +$512K |
|
2477
Global X Cloud Computing ETF
CLOU
$260M
| $679K | ﹤0.01% |
+34,231
| New | +$618K |
|
2478
Goosehead Insurance
GSHD
$2.41B
| $679K | ﹤0.01% |
10,795
-1,738
| -14% | -$99.9K |
|
2479
ADC Therapeutics
ADCT
$140M
| $677K | ﹤0.01% |
314,925
-19,347
| -6% | -$43.5K |
|
2480
Standard Motor Products
SMP
$869M
| $675K | ﹤0.01% |
18,003
+967
| +6% | +$35.3K |
|
2481
Astrana Health
ASTH
$1.8B
| $675K | ﹤0.01% |
21,355
+1,600
| +8% | +$54.9K |
|
2482
OR Royalties Inc
OR
$6.03B
| $673K | ﹤0.01% |
43,801
+31,701
| +262% | +$513K |
|
2483
Alector
ALEC
$168M
| $673K | ﹤0.01% |
111,970
-15,325
| -12% | -$107K |
|
2484
BioXcel Therapeutics
BTAI
$27.1M
| $671K | ﹤0.01% |
6,295
+2,794
| +80% | +$930K |
|
2485
Oil States International
OIS
$499M
| $670K | ﹤0.01% |
89,642
+10,075
| +13% | +$73.5K |
|
|
DOMA
2486
DELISTED
Doma Holdings, Inc.
DOMA
| $668K | ﹤0.01% |
135,177
+132,334
| +4,655% | +$1.06M |
|
2487
Globalstar
GSAT
$10.7B
| $668K | ﹤0.01% |
41,204
-21,866
| -35% | -$351K |
|
|
VRN
2488
DELISTED
Veren
VRN
| $665K | ﹤0.01% |
98,884
+98,883
| +9,888,300% | +$689K |
|
2489
Colliers International
CIGI
$5.19B
| $664K | ﹤0.01% |
+6,766
| New | +$658K |
|
2490
Huron Consulting
HURN
$2.38B
| $664K | ﹤0.01% |
7,823
-2,249
| -22% | -$184K |
|
2491
QCR Holdings
QCRH
$1.73B
| $662K | ﹤0.01% |
16,130
+1,707
| +12% | +$69.9K |
|
2492
Arvinas
ARVN
$550M
| $659K | ﹤0.01% |
26,569
-7,772
| -23% | -$200K |
|
|
BRDG
2493
DELISTED
Bridge Investment Group
BRDG
| $658K | ﹤0.01% |
+57,990
| New | +$590K |
|
2494
PagSeguro Digital
PAGS
$2.65B
| $657K | ﹤0.01% |
69,643
+65,737
| +1,683% | +$666K |
|
2495
Universal Corp
UVV
$1.3B
| $657K | ﹤0.01% |
13,162
+636
| +5% | +$33.4K |
|
2496
ENI
E
$76.8B
| $657K | ﹤0.01% |
22,808
| – | – |
|
2497
Sun Life Financial
SLF
$45.3B
| $656K | ﹤0.01% |
12,595
-17,633
| -58% | -$866K |
|
2498
Appian
APPN
$2.22B
| $656K | ﹤0.01% |
13,789
-6,642
| -33% | -$280K |
|
|
PMT
2499
PennyMac Mortgage Investment
PMT
$819M
| $655K | ﹤0.01% |
48,570
-9,874
| -17% | -$121K |
|
2500
Karat Packaging
KRT
$853M
| $654K | ﹤0.01% |
35,849
-1,781
| -5% | -$27.5K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.